ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy (Q33476874)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy
scientific article

    Statements

    ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy (English)
    Clara I Aceves-Luquero
    Juan L Callejas-Valera
    Laura Arias-González
    Luis del Peso Ovalle
    Itxaso Bellón-Echeverria
    Inmaculada Moreno Gimeno
    Michael W Deininger
    Ricardo Sánchez Prieto

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit